PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35510808-13	2022	PXL065 was confirmed to lack PPARgamma agonism but retained ACSL4 activity of pioglitazone.	Pioglitazone	78-90	acyl-CoA synthetase long chain family member 4	Homo sapiens	60-65	
35038927-6	2022	Most importantly, ferroptosis inhibitors, including two FDA-approved drugs, rosiglitazone (ROSI; ACSL4 inhibitor) and pioglitazone (PIO; ACSL4 inhibitor), decreased the viral load of human enteroviruses and coronaviruses, suggesting that ACSL4 is a target for counteracting viral infection.	Pioglitazone	118-130	acyl-CoA synthetase long chain family member 4	Homo sapiens	137-142	
35038927-6	2022	Most importantly, ferroptosis inhibitors, including two FDA-approved drugs, rosiglitazone (ROSI; ACSL4 inhibitor) and pioglitazone (PIO; ACSL4 inhibitor), decreased the viral load of human enteroviruses and coronaviruses, suggesting that ACSL4 is a target for counteracting viral infection.	Pioglitazone	118-130	acyl-CoA synthetase long chain family member 4	Homo sapiens	238-243